You are about to leave
TRYNGOLZA.com
You will be taken to a third-party site. Ionis is not responsible for the content.
Thank you for visiting TRYNGOLZA.com
The Free Trial Program (FTP) provides eligible patients who are completely new to Tryngolza with a one-time, single dose supply of Tryngolza at no charge to assess the administration process and evaluate the tolerability of Tryngolza. The program is offered through Ionis Pharmaceuticals and is managed by Ionis Every Step™.
To be eligible for the FTP program, a patient must meet ALL the following eligibility criteria:
Patient must not have previously been administered olezarsen or TRYNGOLZA
Ionis Every Step must receive a healthcare provider signed, valid prescription for a U.S. Food and Drug Administration-approved indication for TRYNGOLZA
Available only to patients in the U.S. & its territories
The Ionis Every Step Free Trial Program (“FTP”), sponsored by Ionis Pharmaceuticals, Inc., the manufacturer of TRYNGOLZA, provides a one-time, single-dose of TRYNGOLZA to patients who meet FTP eligibility requirements and who agree to the FTP terms and conditions. FTP is a free trial offer, intended solely to allow patients who are new to TRYNGOLZA to determine with their healthcare provider whether TRYNGOLZA is right for them. There is no obligation to continue use of TRYNGOLZA after the free trial has been completed. To be eligible, a patient must: (1) reside in the United States or its territories; (2) have a valid prescription for TRYNGOLZA for an FDA-approved indication; and (3) not have previously been administered TRYNGOLZA or olezarsen. This offer is limited to one use per patient per lifetime and is non-transferable. TRYNGOLZA supplied through the FTP will (i) be dispensed only by a pharmacy designated by Ionis; (ii) be delivered only to the address specified by the patient (no P.O. boxes) and (iii) not exceed a single-dose supply. No refills are available through the FTP.
It is unlawful for any person to sell, purchase, trade, barter, or export TRYNGOLZA supplied through the FTP or make an offer to do so. Patients, pharmacists, and prescribers may not seek reimbursement, either directly or indirectly, for TRYNGOLZA supplied through the FTP from health insurance or any third-party payer, including Medicare, Medicaid, and commercial insurance plans. Patients must not count the value of the FTP product as an expense incurred for purposes of determining patient out-of-pocket costs under any health insurance program, including Medicare Part D True Out-of-Pocket (“TrOOP”) costs. THE FTP IS NOT HEALTH INSURANCE. The FTP is not a discount, rebate, coupon, cost-sharing program, or other form of financial assistance. You are responsible for any sales tax. Tax charged on pre-offer price where required. No cash back. Obtaining TRYNGOLZA through the FTP is not contingent on any past, present, or future purchase of TRYNGOLZA. Use of the FTP is void where prohibited by law and where use is prohibited by the patient’s insurance provider. Ionis reserves the right to rescind, revoke, or amend the FTP at any time without notice.
Do not use TRYNGOLZA if you have had a serious allergic reaction to TRYNGOLZA or any of the ingredients in TRYNGOLZA.
Before using TRYNGOLZA, tell your healthcare provider about all of your medical conditions, including if you: are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. It is not known if TRYNGOLZA can harm your unborn baby, or if it passes into your breast milk and if it can harm your baby.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of TRYNGOLZA?
TRYNGOLZA can cause side effects including allergic reactions that may be serious. Allergic reactions can include redness of the skin, red itchy bumps (hives), swelling of the face, chills or trouble breathing. Stop taking TRYNGOLZA and call your healthcare provider or get emergency help right away if you have any of these symptoms.
TRYNGOLZA can cause increases in liver enzymes and fat stored inside the liver. Your healthcare provider may do liver tests before you start taking TRYNGOLZA or if there is an increase in your dose. Tell your healthcare provider right away if you have the following symptoms: feeling tired or weak, right upper stomach discomfort, yellowing of the skin and eyes, loss of appetite, or dark colored urine.
The most common side effects of TRYNGOLZA in people with FCS include injection site reactions (such as redness, itching, rash, or pain at the injection site), decreased platelet count (blood cells that help to clot blood), and joint pain or stiffness.
The most common side effects of TRYNGOLZA in people with sHTG include injection site reactions (such as redness, itching, rash, or pain at the injection site) and increased liver enzymes.
These are not all the possible side effects of TRYNGOLZA. Tell your healthcare provider or treatment team about any side effect you may have.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch, or call
1-800-FDA-1088.
TRYNGOLZA (olezarsen) is a prescription medicine used along with diet to:
It is not known if TRYNGOLZA is safe and effective in children.
Please see full Prescribing Information and Patient Information for TRYNGOLZA.
You will be taken to the TRYNGOLZA® healthcare professional site.
Please confirm you are a healthcare professional.